NCT06237296View on ClinicalTrials.gov

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

PHASE1CompletedINTERVENTIONAL
Enrollment

558

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

February 11, 2025

Study Completion Date

February 11, 2025

Conditions
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Interventions
BIOLOGICAL

RSV/hMPV mRNA LNP 1

Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

BIOLOGICAL

RSV/hMPV mRNA LNP 2

Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

BIOLOGICAL

RSV mRNA LNP 1

Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

BIOLOGICAL

hMPV mRNA LNP 1

Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

Trial Locations (17)

2019

Investigational Site Number : 0360002, Botany

2035

Investigational Site Number : 0360004, Sydney

2148

Investigational Site Number : 0360006, Blacktown

2259

Investigational Site Number : 0360003, Kanwal

2617

Investigational Site Number : 0360007, Canberra

3124

Investigational Site Number : 0360001, Camberwell

4006

Investigational Site Number : 0360008, Herston

4506

Investigational Site Number : 0360005, Morayfield

13905

Meridian Clinical Research- Site Number : 8400007, Binghamton

22911

Charlottesville Medical Research Center Winding River - Site Number : 8400002, Charlottesville

29405

Coastal Carolina Research Center- Site Number : 8400001, North Charleston

33009

Velocity Clinical Research-Hallandale Beach- Site Number : 8400013, Hallandale

44122

Velocity Clinical Research- Site Number : 8400012, Cleveland

51106

Velocity Clinical Research, Sioux City Site Number : 8400017, Sioux City

70119

Velocity Clinical Research- New Orleans Site Number : 8400016, New Orleans

83642

Advanced Clinical Research- Site Number : 8400005, Meridian

90247

Velocity Gardena Site Number : 8400011, Gardena

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT06237296 - Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older | Biotech Hunter | Biotech Hunter